Radiopharm Theranostics
Logotype for Radiopharm Theranostics Limited

Radiopharm Theranostics (RAD) investor relations material

Radiopharm Theranostics Emerging Growth Conference 89 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Radiopharm Theranostics Limited
Emerging Growth Conference 89 summary21 Jan, 2026

Conference overview

  • The event is the 89th Emerging Growth Conference, featuring presentations from clinical-stage companies in innovative sectors.

  • Radiopharm Theranostics presented its pipeline and strategic direction, focusing on radiopharmaceuticals for high unmet medical needs.

Pipeline and clinical progress

  • Five molecules are in clinical stage, with four highlighted: a phase II imaging agent for brain metastasis and three therapeutic agents targeting PD-L1, HER2, and B7-H3.

  • The brain metastasis imaging agent (RAD101) is over 50% recruited in phase II, with positive interim data showing 92% concordance with MRI and potential for earlier tumor detection.

  • Therapeutic agents are progressing through dose escalation with favorable safety and tumor uptake; B7-H3 monoclonal antibody is ready to dose first patients.

Competitive positioning and partnerships

  • The company claims first-in-class status for its imaging and PD-L1 agents, with limited or no direct competition in current clinical stages.

  • Strategic partnerships include Lantheus (15% shareholder) and MD Anderson Cancer Center, supporting both development and supply chain security.

  • The supply chain for isotopes is diversified across multiple continents, ensuring readiness for late-stage trials and commercialization.

RAD101's 4-month early detection: market impact?
Partnership strategy for Phase III and commercialization
B7-H3 lead over Novartis: critical for market share?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Radiopharm Theranostics earnings date

Logotype for Radiopharm Theranostics Limited
Q2 202626 Feb, 2026
Radiopharm Theranostics
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Radiopharm Theranostics earnings date

Logotype for Radiopharm Theranostics Limited
Q2 202626 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Radiopharm Theranostics Limited is a biotechnology company focused on the development of radiopharmaceutical products for the diagnosis and treatment of cancer. The company specializes in theranostics, combining therapeutic and diagnostic capabilities into a single platform. Its pipeline includes targeted radiopharmaceuticals designed to deliver precision treatments while enabling imaging for monitoring disease progression. The company is headquartered in Melbourne, Australia, and its shares are listed on the ASX.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage